Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures.
Melt Pharmaceuticals has raised $24.0M in total funding. The most recent round was Series B. The last funding was announced in April 2024.
Melt Pharmaceuticals is headquartered in Brentwood, United States.
Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures.
Melt Pharmaceuticals is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Melt Pharmaceuticals — Funding & Investors." VCBacked, April 2, 2024, https://www.vcbacked.co/company/melt-pharmaceuticals. Accessed October 2, 2026.
VCBacked. (2024). Melt Pharmaceuticals — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/melt-pharmaceuticals
{{cite web |title=Melt Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/melt-pharmaceuticals |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated